Literature DB >> 14568169

Reduced protein degradation rates and low expression of proteolytic systems support skeletal muscle hypertrophy in transgenic mice overexpressing the c-ski oncogene.

Paola Costelli1, Neus Carbó, Sílvia Busquets, Francisco J López-Soriano, Francesco M Baccino, Josep M Argilés.   

Abstract

We have investigated the protein turnover modulations involved in the hypertrophic muscle phenotype of c-ski overexpressing transgenic mice. In these animals, the body weight is increased and all the muscles examined show a definite hypertrophy. The protein degradation rate is significantly reduced in the fast twitch muscles of c-ski transgenic animals with respect to controls; in contrast, there are no detectable differences in the synthesis rates. The down-regulation of protein breakdown is paralleled by decreased expression of genes belonging to the lysosomal as well as to the ATP-ubiquitin-dependent proteolytic pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568169     DOI: 10.1016/s0304-3835(03)00415-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Coping with cold: An integrative, multitissue analysis of the transcriptome of a poikilothermic vertebrate.

Authors:  Andrew Y Gracey; E Jane Fraser; Weizhong Li; Yongxiang Fang; Ruth R Taylor; Jane Rogers; Andrew Brass; Andrew R Cossins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

2.  Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.

Authors:  Angeles C Tecalco-Cruz; Diana G Ríos-López; Genaro Vázquez-Victorio; Reyna E Rosales-Alvarez; Marina Macías-Silva
Journal:  Signal Transduct Target Ther       Date:  2018-06-08

3.  Nucleus Type-Specific DNA Methylomics Reveals Epigenetic "Memory" of Prior Adaptation in Skeletal Muscle.

Authors:  Yuan Wen; Cory M Dungan; C Brooks Mobley; Taylor Valentino; Ferdinand von Walden; Kevin A Murach
Journal:  Function (Oxf)       Date:  2021-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.